BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2012
View Archived Issues
Lundbeck reports on second quarter of 2012
Read More
Additional causes of startle disease identified / News in Context
Read More
Combination regimen shows efficacy in patients with tuberculosis
Read More
Astellas Pharma announces highlights for second quarter of 2012
Read More
Mitsubishi Tanabe Pharma reviews second quarter 2012
Read More
Multiple new global ALS research grants issued
Read More
Amylin satisfies financial obligations to Lilly for exenatide
Read More
Marqibo receives accelerated approval
Read More
Sosei transfers SD-118 rights
Read More
Phase III AVAglio trial meets coprimary endpoint
Read More
Pirfenidone approved in South Korea
Read More
Novel pim kinase inhibitors synthesized in Spain
Read More
Research in Malaysia yields new curcumin derivatives
Read More
Novel GPR119 agonists disclosed by Boehringer Ingelheim Pharma
Read More
Convergence Pharmaceuticals reports novel candidate analgesics
Read More
Scientists in Italy and U.S. jointly develop new 3-HAO inhibitors
Read More
German team designs new candidate drugs for cardiovascular diseases
Read More
Recombinant hypoallergenic combination vaccines developed for house dust mite allergy
Read More
Intercept Pharmaceuticals secures funds for development of its lead product
Read More
Data presented on temsirolimus combination regimen in kidney cancer
Read More
FDA places clinical hold on anthrax vaccine program
Read More
Elan announces planned spin-off
Read More
FDA approves first drug for diabetic macular edema
Read More
Pluristem Therapeutics reports on PLX-PAD trial
Read More
Phase III study of OCV-C01 advances
Read More